3,143 hedge funds and large institutions have $201B invested in Pfizer in 2022 Q2 according to their latest regulatory filings, with 129 funds opening new positions, 1,399 increasing their positions, 1,257 reducing their positions, and 122 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more first-time investments, than exits

New positions opened: | Existing positions closed:

3% more capital invested

Capital invested by funds: $196B → $201B (+$5.15B)

1% more call options, than puts

Call options by funds: $2.9B | Put options by funds: $2.89B

1% less funds holding

Funds holding: 3,1823,143 (-39)

Holders
3,143
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
251
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.9B
Puts
$2.89B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$504M
52
$492M
53
$486M
54
$478M
55
$474M
56
$460M
57
$444M
58
$425M
59
$421M
60
$403M
61
$402M
62
$400M
63
$399M
64
$392M
65
$391M
66
$385M
67
$377M
68
$367M
69
$362M
70
$352M
71
$344M
72
$338M
73
$325M
74
$324M
75
$314M